News Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Dec 3, 2015
ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced it has...
-
Nov 11, 2015
ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced that Dr....
-
Nov 5, 2015
ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today reported its financial...
-
Oct 29, 2015
- First patient dosed in clinical trial evaluating DNAi interference (DNAi®) - VANCOUVER, Oct. 29, 2015 /CNW/ - ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company...
-
Aug 21, 2015
Completed Upsized Initial Public Offering, Raising Gross Proceeds of $158.4 Million Advanced Clinical Programs for PNT2258 in DLBCL and Richter's Transformed CLL Strengthened Management Team and...